Charlie King

Advertisment NMPA approves Redemplo (plozasiran) for familial chylomicronemia syndrome in China – Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals, Inc. announced that the Chinese National Medical Products Administration (NMPA) has approved Redemplo (p... See more

Advertisment Identifying injury mechanisms influencing the severity of knee injuries in rugby Knee injuries in rugby players occur with high incidence and severity, posing a significant burden on athletes. Although many studies on rugby injuries have been... See more

Advertisment EU approves Tremfya (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor – Johnson & Johnson Johnson & Johnson announced that the European Commission (EC) has... See more

China has achieved significant advancements in gastroenterology and digestive endoscopy, according to the 2024 national report published in the Chinese Medical Journal . Drawing data from the National Clinical Improvement System (NCIS) and Hospital Qualit... See more

Korab Zuka: Leading Sustainability at Novartis Charlie King Novartis, one of the world’s largest pharmaceutical companies, has sharpened its sustainability focus under the leadership of Korab Zuka, who took the role of Global Head of Social Impact and Chi... See more